Neoplastic Meningitis from Solid Tumors: A Prospective Clinical Study in Lombardia and a Literature Review on Therapeutic Approaches
Open Access
- 16 January 2013
- journal article
- review article
- Published by Hindawi Limited in Journal of Drug Delivery
- Vol. 2013, 1-6
- https://doi.org/10.1155/2013/147325
Abstract
Neoplastic dissemination to the leptomeninges is an increasingly common occurrence in patients with both haematological and solid tumors arising outside the central nervous system. Both refinement of diagnostic techniques (Magnetic resonance imaging) and increased survival in patients treated with targeted therapies for systemic tumors account for this increased frequency. Cerebrospinal fluid cytological analysis and MRI confirm clinical diagnosis based on multifocal central nervous system signs/symptoms in a patient with known malignancy. Overall survival in patients with leptomeningeal neoplastic dissemination from solid tumors is short, rarely exceeding 3-4 months. However, selected patients may benefit from aggressive therapies, Apart from symptomatic treatment, intrathecal chemotherapy is used, with both free (methotrexate, Thiotepa, AraC) and liposomal antitumor agents (liposomal AraC). Palliative radiotherapy is indicated only in cases of symptomatic bulky disease, surgery is limited to positioning of Ommaya recervoirs or C5F shunting. We report clinical data on a cohort of 26 prospectively followed patients with neoplastic leptomeningitis followed in Lombardia, Italy, in 2011. Prognostic factors and pattern of care are reported.Keywords
This publication has 21 references indexed in Scilit:
- Neoplastic Meningitis from Solid Tumors: New Diagnostic and Therapeutic ApproachesThe Oncologist, 2011
- Leptomeningeal metastasisCurrent Opinion in Oncology, 2010
- Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow CytometryJournal of Clinical Oncology, 2009
- Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-CJournal of Neuro-Oncology, 2008
- Successful Treatment of Leptomeningeal Disease in Colorectal Cancer With a Regimen of Bevacizumab, Temozolomide, and IrinotecanJournal of Clinical Oncology, 2007
- Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaBlood, 2007
- Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphomaLeukemia & Lymphoma, 2007
- High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytologyBlood, 2005
- The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised studyEuropean Journal Of Cancer, 2004
- A comparison between ventricular and lumbar cerebrospinal `uid cytology in adult patients with leptomeningeal metastasesNeuro-Oncology, 2001